Hypofractionated moderate dose radiation, intrathecal chemotherapy, and repetitive reinduction/reconsolidation systemic therapy for central nervous system relapse of acute lymphoblastic leukemia in children

Medical and Pediatric Oncology

Volumn 34, Issue 2, 2000, Pages 125-131

  Belasco, Jean B ^a,d   Goldwein, Joel W ^a   Simms, Steven ^a   Griffin, Gregory ^b,c   D'Angio, Giulio ^a   Lange, Beverly ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Acute lymphoblastic leukemia; CNS relapse

Indexed keywords

ASPARAGINASE; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; HYDROCORTISONE; METHOTREXATE; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BRAIN LEUKEMIA; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; INFANT; MALE; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY DOSAGE; SURVIVAL RATE;

EID: 0033966718     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(200002)34:2<125::AID-MPO10>3.0.CO;2-K     Document Type: Article

References (56)

1. Evans A. Central nervous system involvement in children with acute leukemia. A study of 921 patients. Cancer 1964;17:256-258.
2. Hardisty R, Norman P. Meningeal leukemia. Arch Dis Child 1967;42:442-447.
3. Evans A, Gilbert E, Zandstra R. The increasing incidence of central nervous system leukemia in children. Cancer 1970;26:404-409.
4. Bleyer WA, Poplack DH. Prophylaxis and treatment in the central nervous system and other sanctuaries. Semin Oncol 1985;12:131-148.
5. George S, Ochs J, Mauer A. The importance of an isolated central nervous system relapse in children with acute lymphoblastic leukemia. J Clin Oncol 1985;3:776-781.
6. Bleyer WA. Central nervous system leukemia. Pediatr Clin North Am 1988;35:789-814.
7. Ortega JA, Nesbit ME, Sather HN, et al. Long-term evaluation of a CNS prophylaxis trial - treatment comparisons and outcome after CNS relapse in childhood ALL: a report from the Children's Cancer Study Group. J Clin Oncol 1987;5:1646-1654.
8. Nesbit ME, Robison LL, Litman P, et al. Presymptomatic central nervous system therapy in previously untreated childhood acute lymphoblastic leukemia: comparison of 1800 RAD and 2400 RAD: a report for the Children's Cancer Study Group. Lancet 1981;1:1386-1389.
9. Blaney SM, Poplack DG. Central nervous system leukemia [see comments; review; 38 refs]. Curr Opin Oncol 1996;8:13-19.
10. Rivera GK, Pui CH, Hancock ML, et al. Update of St Jude Study XI for childhood acute lymphoblastic leukemia. Leukemia 1992;6(Suppl 2):153-156.
11. Ribeiro RC, Rivera GK, Hudson M, et al. An intensive retreatment protocol for children with an isolated CNS relapse of acute lymphoblastic leukemia. J Clin Oncol 1995;13:333-338.
12. Steinherz PG. CNS leukemia: problem of diagnosis, treatment, and outcome [editorial]. J Clin Oncol 1995;13:310-313.
13. Morgan E, Donaldson M, Meadows A. The value of maintenance therapy following treatment of central nervous system leukemia. Cancer 1977;40:1005-1009.
14. Kun LE, Camitta BM, Mulhern R, et al. Treatment of meningeal relapse in childhood leukemia: results of craniospinal irradiation. J Clin Oncol 1984;2:359-364.
15. Winick NJ, Smith SD, Shuster J, et al. Treatment of CNS relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group study. J Clin Oncol 1993;11:271-278.
16. Bode U, Diehl M, Koster B. Acute encephalopathy following cranial irradiation of previously treated meningeal leukemia [in German]. Strahlenther Onkol 1986;162(10):618-620.
17. Garcia-Tena J, Lopez-Andreu JA, Ferris J, et al. Intrathecal chemotherapy-related myeloencephalopathy in a young child with acute lymphoblastic leukemia. Pediatr Hematol Oncol 1995;12: 377-385.
18. Belasco J, Rate W, Mancini A, et al. Intermittent low-dose central nervous system prophylaxis for high-risk pediatric leukemia patients: preliminary results. Med Pediatr Oncol 1991;10:106-109.
19. Ritchey SK, Pollock BH, Lauer S. Delayed craniospinal irradiation with intensified chemotherapy for isolated meningeal relapse of childhood acute lymphoblastic leukemia [abstract]. Blood 1993;82(Suppl 1):195.
20. Buhrer C, Hartmann R, Fengler R, et al. Peripheral blast counts at diagnosis of late isolated bone marrow relapse of childhood acute lymphoblastic leukemia predict response to salvage chemotherapy and outcome. Berlin-Frankfurt-Munster Relapse Study Group. J Clin Oncol 1996;14:2812-2817.
21. Balsom WR, Bleyer WA, Robison LL, et al. Intellectual function in long-term survivors of childhood acute lymphoblastic leukemia: protective effect of pre-irradiation methotrexate? A Children's Cancer Study Group study. Med Pediatr Oncol 1991;19: 486-492.
22. Berry DH, Elders MJ, Crist W, et al. Growth in children with acute lymphoblastic leukemia: a Pediatric Oncology Group study. Med Pediatr Oncol 1983;11:39-45.
23. Goldwein JW, Meadows AT. Influence of radiation on growth in pediatric patients [review; 49 refs]. Clin Plast Surg 1993;20:455-464.
24. Katz JA, Pollock BH, Jacaruso D, Morad A. Final attained height in patients successfully treated for childhood acute lymphoblastic leukemia. J Pediatr 1993;123:546-552.
25. Meadows A, Massari D, Fergusson J, et al. Declines in IQ scores and cognitive dysfunctions in children with acute lymphocytic leukemia treated with cranial irradiation. Lancet 1981;10:1015-1018.
26. Moell C, Garwica S. Influence of treatment modalities on prepubertal growth in children with acute lymphoblastic leukemia. Pediatr Hematol Oncol 1995;12:425-427.
27. Moore IM, Kramer JH, Wara W, et al. Cognitive function in children with leukemia. Pediatr Hematol Oncol 1991;12:1913-1917.
28. Mulhern R, Fairclough, Ochs J. A prospective comparison of neuropsychologic performance of children surviving leukemia who received 18 Gy-, 24 Gy- or no cranial irradiation. J Clin Oncol 1991;9:1348-1356.
29. Robison LL, Nesbit ME, Sather HN, et al. Height of children successfully treated for acute lymphoblastic leukemia: a report from the Late Effects Study Committee of the Children's Cancer Study Group. Med Pediatr Oncol 1985;13:14-21.
30. Halberg FE, Kramer JH, Moore IM, et al. Prophylactic irradiation dose effects on late cognitive function in children treated for acute lymphoblastic leukemia. Int J Rad Oncol Biol Phys 1992;22:13-16.
31. Silber JH, Radcliffe J, Peckham V, et al. Whole brain irradiation and decline in intelligence: the influence of dose and age on IQ score. J Clin Oncol 1992;10:1390-1396.
32. Sklar C, Mertens A, Walter A, et al. Final height after treatment for childhood acute lymphoblastic leukemia: comparison of no cranial irradiation with 1800 and 2400 centigrays of cranial irradiation. J Pediatr 1993;123:59-64.
33. Waber DP, Tarbell NJ, Kahn CM, et al. The relationship of sex an treatment modality to neuropsychological outcome in childhood acute lymphoblastic leukemia. J Clin Oncol 1991;10:810-817.
34. Belasco J, Luery N, Scher C. Multiagent chemotherapy in relapsed acute lymphoblastic leukemia in children. Cancer 1990;66: 2492-2497.
35. Zuezler W, Ravindranath Y, Lusher J, et al. Intermittent intrathecal methotrexate and fractional radiation plus chemotherapy in childhood leukemia. Am J Hematol 1976;1:191-199.
36. Ravindranath Y, Soorya D, Schultz G, Lusher J. Long-term survivors of acute lymphoblastic leukemia-risk of relapse after cessation of therapy. Med Pediatr Oncol 1981;9:209-218.
37. Mastrangelo R, Poplack D, Bleyer W. Report and recommendations of the Rome Workshop concerning poor-prognosis acute lymphoblastic leukemia in children: biologic basis for staging, stratification, and treatment. Med Pediatr Oncol 1986;14:191-194.
38. Tubergen DG, Gilchrist GS, O'Brien RT, et al. Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy: a Children's Cancer Group report. J Clin Oncol 1993;11:520-526.
39. Krick J. Using the Z score as a descriptor of discrete changes in growth. Nutr Support Serv 1986;6:14-21.
40. Weschler D. Manual for the Weschler Intelligence Scale for Children-Revised (WISC-R). San Antonio, TX: The Psychological Corporation. 1974.
41. Weschler D. Manual for the Weschler preschool and primary scale of intelligence-revised (WPPSI-R). San Antonio, TX: The Psychological Corporation. 1989.
42. Weschler D. Manual for the Wechsler intelligence scale for children - third edition (WISC-III). The Psycholgical Corporation, San Antonio, Texas. 1991.
43. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
44. Rosner B. Fundamentals of biostatistics. Boston: Duxbury Press; 1986. p 54.
45. Smith M, Arthur D, Camitta B. Uniform approach to risk classification and therapy for children with acute lymphoblastic leukemia. J Clin Oncol 1996;14:18.
46. Steinherz P, Jereb B, Galicich J. Therapy of CNS leukemia with intraventricular chemotherapy and low-dose neuraxis radiotherapy. J Clin Oncol 1985;3:1217-1226.
47. Kim TH, Ramsay NK, Steeves RA, Nesbit ME. Intermittent central nervous system irradiation and intrathecal chemotherapy for central nervous system leukemia in children. Int J Rad Oncol Biol Phys 1987;13:1451-1455.
48. Wells R, Weetman R, Baehner R. The impact of isolated central nervous system relapse following initial complete remission in childhood acute lymphocytic leukemia. J Pediatr 1980;97:429-432.
49. Considine B Jr, Cook JJ, Zuelzer WW, et al. Repetitive low dose radiation therapy for acute stem cell leukemia. Int J Rad Oncol Biol Phys 1977;2:257-260.
50. Gomez-Almaguer D, Gonzalez-Llano O, Montemayor J, et al. Dexamethasone in the treatment of meningeal leukemia. Am J Hematol 1995;49:353-354.
51. Morra E, Lazzarino M, Inverardi D, et al. Systemic high-dose ara-C for the treatment of meningeal leukemia in adult acute lymphoblastic leukemia and non-Hodgkin's lymphoma. J Clin Oncol 1986;4:1207-1211.
52. Nowrousian MR, Seeber S, Miller AA, et al. High-dose cytarabine treatment in acute leukemias and leukemic meningiosis: clinical aspects and pharmacokinetics [in German]. Onkologie 1985;8:26-32.
53. Capizzi R, White J, Powell B, Perrino F. Effect of dose on the pharmacokinetic and pharmacodynamic effects of cytarabine. Semin Hematol 1991;28:54-69.
54. Mahmoud HH, Rivera GK, Hancock ML, et al. Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia. N Engl J Med 1993;329:314-319.
55. McIntosh S, Ritchey AK. Diagnostic problems in cerebrospinal fluid of children with lymphoid malignancies. Am J Pediatr Hematol Oncol 1986;8:28-31.
56. Tubergen D, Cullen J, Boyett J, et al. Blasts in CSF with a normal cell count do not justify alteration of therapy for acute lymphoblastic leukemia in remission: a Children's Cancer Group study. J Clin Oncol 1994;12:272-278.